HB 1716 (see companion bill SB 1007) – MarylandStatus: Inactive / Dead
Year Introduced: 2018
PRESCRIPTION DRUG MONITORING PROGRAM: Requiring the Prescription Drug Monitoring Program to disclose prescription drug monitoring data, in accordance with certain regulations, to certain insurance carriers for determining the medical necessity of a prescription drug claim, enhancing or coordinating patient care, or assisting the treating provider’s clinical decision making.
Return to Database Search
© 2018-2019 The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.